As part of the transition to a newly regulated market, California marijuana regulators will hand out temporary business licenses to existing companies starting Jan. 1. Lori Ajax, chief of the state’s Bureau of Cannabis Control, made the announcement Thursday at the California Cannabis Business Conference in Anaheim. To qualify for a temporary permit, businesses will […]Read More
By Kristen Nichols
A recent memo from Nebraska’s top law-enforcement official – in which he called cannabidiol products “illegal” – has underscored the challenges faced by CBD manufacturers and retailers nationwide.
The memo, and a CBD brouhaha in Indiana, have meant lost sales, confiscated product, legal uncertainty – and even the loss of a job.Read More
Details are starting to emerge about Michigan’s new medical marijuana licensing rules. Michigan’s medical cannabis businesses will be allowed to grow, process and sell MMJ at the same location once a new statewide MMJ regulatory system is up and running, the Department of Licensing and Regulatory Affairs said Thursday. Potential medical cannabis licensees who want […]Read More
West Virginia regulators are anticipating the state will need about $2 million to launch its medical marijuana program. State health officer Dr. Rahul Gupta told both the state Senate and the House of Delegates the program could potentially be funded through an “internal loan,” the Charleston Gazette-Mail reported. The biggest portion of the program’s expected […]Read More
The Oregon Secretary of State plans to audit the state’s recreational marijuana regulatory agency and how the program enforces cannabis rules. According to The Oregonian, the audit announcement precedes a Tuesday visit to Oregon by U.S. Attorney General Jeff Sessions, who wrote to Gov. Kate Brown this summer expressing concerns that the state has been unsuccessful […]Read More
Arkansas received roughly 300 applications for medical marijuana business licenses, including about 200 on the final day the paperwork could be submitted. The Department of Finance and Administration took in 200-plus applications Monday on top of the roughly 100 that had been submitted since the process began, the Arkansas Democrat-Gazette reported. The turnout likely was […]Read More
By John Schroyer Two local ballot measures to grow Detroit’s once-sizable medical marijuana industry have overcome significant legal hurdles and will now go before voters in November. The proposed changes, if approved by voters, would likely result in a broadening of the MJ-related business opportunities in Michigan’s biggest city.Read More
Nevada’s marijuana distribution court fight will last at least another few weeks. On Friday, the Nevada state Supreme Court issued a temporary injunction prohibiting the Department of Taxation from issuing any more marijuana distribution licenses, in a move that could extend supply chain problems for cannabis retailers in the short term. Oral arguments in the case […]Read More
The Trump administration hasn’t yet decided what to do about marijuana enforcement in states that have legal cannabis programs, according to a top Department of Justice official who was asked about marijuana policy. “We’re looking at it,” Rod Rosenstein, the No. 2 enforcement official at the Department of Justice, said of the Obama-era Cole Memo meant […]Read More
By Bart Schaneman, John Schroyer and Omar Sacirbey A new legal interpretation says marijuana consumption lounges don’t violate Nevada law, U.S. senators are calling for national cannabis testing protocols, and Maine releases draft rules for its recreational MJ industry. Here’s a closer look at some notable developments in the marijuana industry over the past week.Read More
Medical cannabis just found an unlikely ally in Utah Republican Orrin Hatch. Hatch, who has served in the U.S. Senate since 1977, has introduced the Marijuana Effective Drug Study Act of 2017 (MEDS Act), according to Fortune. If approved by Congress, the bipartisan measure would ease barriers to research into the potential medical benefits of cannabis. […]Read More
Producers and retailers of CBD products have a few more days to try to discourage international health regulators from classifying the substance as a psychotropic drug.
The U.S. Food and Drug Administration announced last month it wants comments about CBD to send to the World Health Organization. The deadline for comments has been extended a week to midnight ET Sept. 20.
The FDA plans to forward the comments to the WHO without recommending an action.Read More
- 23 hours agoNovember 20, 2017November 20, 2017November 20, 2017
- November 20, 2017November 20, 2017November 20, 2017November 20, 2017November 20, 2017November 17, 2017November 17, 2017November 17, 2017
- November 17, 2017November 16, 2017November 16, 2017November 16, 2017November 16, 2017November 16, 2017November 15, 2017November 15, 2017
Read the Issue